L957-0065 Screening compound: 1-(2-methoxyphenyl)-4-{5-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,3,4-oxadiazole-2-carbonyl}piperazine

L957-0065 Screening compound: 1-(2-methoxyphenyl)-4-{5-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,3,4-oxadiazole-2-carbonyl}piperazine
L957-0065 Screening compound: 1-(2-methoxyphenyl)-4-{5-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,3,4-oxadiazole-2-carbonyl}piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound L957-0065
1-(2-methoxyphenyl)-4-{5-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,3,4-oxadiazole-2-carbonyl}piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L957-0065

Molecular Formula

C24H27N5O5S (C24 H27 N5 O5 S)

Compound Name

1-(2-methoxyphenyl)-4-{5-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,3,4-oxadiazole-2-carbonyl}piperazine

IUPAC name

1-(2-methoxyphenyl)-4-{5-[4-(pyrrolidine-1-sulfonyl)phenyl]-134-oxadiazole-2-carbonyl}piperazine

SMILES

COc(cccc1)c1N(CC1)CCN1C(c1nnc(-c(cc2)ccc2S(N2CCCC2)(=O)=O)o1)=O

InChI

InChI=1S/C24H27N5O5S/c1-33-21-7-3-2-6-20(21)27-14-16-28(17-15-27)24(30)23-26-25-22(34-23)18-8-10-19(11-9-18)35(31,32)29-12-4-5-13-29/h2-3,6-11H,4-5,12-17H2,1H3

InChI Key

BVTUSAGHMCVAJO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27489567

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

497.58

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.458

Distribution Coefficient, logD

2.457

Water Solubility, LogSw

-2.58

Polar Surface Area

90.069

Acid Dissociation Constant (pKa)

27.94

Base Dissociation Constant (pKb)

5.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.50

L957-0065 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Angiogenesis library (14822 compounds)

GPCR Targeted Library (31838 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L957-0065 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L957-0065?
Check Price and Availability of L957-0065, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L957-0065 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L957-0065
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L957-0065
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L957-0065 available by request